Pharmacodynamics of colistin against Acinetobacter baumannii

QR Code

Pharmacodynamics of colistin against Acinetobacter baumannii

Nosocomial infection caused by Acinetobacter baumannii is endemic in hospital settings especially among immunocompromised patients. Treatment strategy is limited due to rapid emergence of extensively drug resistance and lack of novel agent in the antibiotic development pipeline. Colistin has been th...

Full description

Bibliographic Details
Main Author:	Mohd Rasidin, Rashizal Sazli
Format:	Thesis
Language:	English
Published:	2017
Subjects:	Colistin - pharmacology Acinetobacter baumannii
Online Access:	http://psasir.upm.edu.my/id/eprint/70949/ http://psasir.upm.edu.my/id/eprint/70949/1/FPSK%28M%29%202017%2013%20-%20IR.pdf

Similar Items

Molecular epidemiology of multiple drug resistant Acinetobacter baumannii from a major teaching hospital in Malaysia
by: Moghaddam, Mohammad Reza Babaei
Published: (2016)

Quorum sensing and surface attachment in Acinetobacter baumannii
by: Lopez Martin, Mario
Published: (2020)

Testing the effects of prey surface changes on Bdellovibrio bacteriovorus predation
by: Lai, Ting
Published: (2019)

Hexavalent molybdenum reduction to mo-blue by acinetobacter calcoaceticus
by: Abd. Shukor , Mohd. Yunus, et al.
Published: (2010)

Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii
by: Mahamad Maifiah, Mohd Hafidz, et al.
Published: (2017)

The roles of polyamines in ESKAPE pathogens
by: Jackson, Samuel G.
Published: (2024)

Biodegradation Of Diesel By A Locally Isolated Acinetobacter Sp.
by: Dahalan, Farrah Aini
Published: (2007)

Biodegradation of phenol by locally isolated Acinetobacter sp. strain AQ5NOL 1 and purification of phenol hydroxylase
by: Ahmad, Siti Aqlima
Published: (2011)

Rational design and synthesis of modified teixobactin analogues: in vitro antibacterial activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa
by: Ng, Vivian, et al.
Published: (2018)

Global metabolic analyses of acinetobacter baumannii
by: Mahamad Maifiah, Mohd Hafidz, et al.
Published: (2019)

Pharmacodynamics for Medical Students
by: Lim, William/W.K.
Published: (2014)

Colistin-associated nephrotoxicity among patients in intensive care units (ICU) of hospitals in Selangor
by: Mohd Rasidin, Rashizal Sazli, et al.
Published: (2017)

Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii
by: Mahamad Maifiah, Mohd Hafidz, et al.
Published: (2016)

Demonstration Of Antigenic And Specific Outer Membrane Protein(S) Of Acinetobacter Baumannii
by: Shafiqul Islam, A.H.M.
Published: (2009)

Developing and validating a new comprehensive glucose-insulin pharmacokinetics and pharmacodynamics model
by: Ummu Kulthum, Jamaludin
Published: (2013)

Demonstration of antigenic and specific surface association heat shock protein(s) of acinetobacter baumannii
by: Hasnur, Nur Nadhra Adila
Published: (2018)

Characterization and identification of newly isolated Acinetobacter baumannii strain Serdang 1 for phenol removal
by: Mohamad Yadzir, Zailatul Hani, et al.
Published: (2012)

Delineating the plausible molecular vaccine candidates and drug targets of multidrug-resistant Acinetobacter baumannii
by: Mujawar, Shama *, et al.
Published: (2019)

Acinetobacter baumannii strain 6.1 16S ribosomal RNA gene, partial sequence
by: Kamarudin, Kamarul Rahim, et al.
Published: (2012)

Occurrence of multidrug-resistant Acinetobacter baumannii and Escherichia coli in veterinary health care facilities
by: Ng, Joanna Sze Yi
Published: (2015)

The characterisation of carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae in a teaching hospital in Malaysia
by: Lau, Min Yi, et al.
Published: (2024)

Phenotypic and molecular characterisation of clinical carbapenem-resistant acinetobacter baumannii / Kong Boon Hong
by: Kong, Boon Hong
Published: (2012)

The mazEF toxin-antitoxin system as a novel antibacterial target in Acinetobacter baumannii
by: Ghafourian, Sobhan, et al.
Published: (2014)

Antibacterial and antibiofilm properties of salvadora persica extracts against carbapenem-resistant acinetobacter baumannii isolated from endotracheal tube samples
by: Alias, Wan Alif Syazwani Wan
Published: (2024)

Genomic adaptation in antimicrobial resistance: Elucidating the route and effects in acinetobacter baumannii / Mohamad Izwan Ismail
by: Ismail, Mohamad Izwan
Published: (2016)

Genomic adaptation in antimicrobial resistance: elucidating the route and effects in Acinetobacter baumannii / Mohamad Izwan Ismail
by: Ismail, Mohamad Izwan
Published: (2016)

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
by: Abd. Rahman, Nurul Azrin, et al.
Published: (2013)

Characterization of a molybdenum-reducing Acinetobacter baumannii strain Serdang 1 with the capacity to grow on phenol and acrylamide
by: Mohamad Yadzir, Zailatul Hani, et al.
Published: (2016)

Unravelling virulence activities of hospital isolated acinetobacter baumannii: exploring the prospective application of aspirin as an antivirulence agent
by: Nurrul Syairah A Shukor,, et al.
Published: (2024)

Occurrence of multidrug-resistant Acinetobacter baumannii and Escherichia coli in veterinary healthcare facilities in Klang Valley, Malaysia
by: Ng, S. Y., et al.
Published: (2016)

Molecular characterization and comparative genomics of multidrug resistant acinetobacter baumannii from Malaysia / Lean Soo Sum
by: Lean, Soo Sum
Published: (2016)

Phenol removal by newly isolated Acinetobacter baumannii strain Serdang 1 in a packed-bed column reactor
by: Mohamad Yadzir, Zailatul Hani, et al.
Published: (2016)

Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2015)

Antimicrobial susceptibility and molecular profiles of acinetobacter baumannii in Makkah hospitals, and the potential use of bacteriophage as a treatment option
by: Raees, Fahad
Published: (2022)

Metabolic responses to polymyxin treatment in acinetobacter baumannii ATCC 19606: integrating transcriptomics and metabolomics with genome-scale metabolic modeling
by: Zhu, Yan, et al.
Published: (2019)

Effect Of Crude Aldehyde Dehydrogenase On The Degradation Of Crude Oil By A Local Isolate, Acinetobacter Baumannii Fetl C4
by: Chee , Mei Sing
Published: (2010)

Pharmacokinetic/pharmacodynamics-optimized antimicrobial therapy in patients with hospital-acquired pneumonia/ventilator-associated pneumonia
by: Sulaiman, Helmi, et al.
Published: (2017)

Development of a dna-based method for simultaneous detection of acinetobacter baumannii, antimicrobial resistance genes and its genotypes by dna fingerprinting
by: Ee, Chan Shiao
Published: (2017)

The clinical and molecular characterization of extensively drug resistant (XDR) acinetobacter baumannii complex from clinical isolates in Hospital Raja Perempuan Zainab II
by: Puat, Mahirah Kamil
Published: (2018)

Metabolic capability of Acinetobacter baumannii based on phenotype microarray analysis and the effects of selected substrates on its biofilm forming ability / Ahlam Hodaed Alsheikh
by: Ahlam Hodaed , Alsheikh
Published: (2018)